Literature DB >> 7357814

Effect of cardiopulmonary bypass on cefazolin disposition.

K W Miller, H G McCoy, K K Chan, R P Fischer, W G Lindsay, R D Seifert, D E Zaske.   

Abstract

Cefazolin kinetics was studied in 8 patients the day before (PREOP), during (SURG), and the day after (POSTOP) cardiopulmonary bypass (CPB) surgery. PREOP (48.6 ml/min) and POSTOP (46.6 ml/min) total body clearances were of the same order and both were greater than the SURG (27.4 ml/min) total body clearance. Since cefazolin is almost entirely eliminated by the kidney, the lower SURG clearance is a result of reduced renal elimination, as confirmed by measuring cefazolin SURG (28.7 ml/min) and POSTOP (52.9 ml/min) renal clearance. The reduction in cefazolin renal elimination was the same throughout the surgical procedure, including the period of extracorporeal circulation. Cefazolin distribution was altered by the operative procedure as evidence by a higher SURG steady-state volume of distribution. This increase in apparent cefazolin distribution volume brought about by surgery was not seen with cephalothin, which was investigated by us in a similar group of patients. The different effect of CPB surgery on cefazolin and cephalothin distribution may be due to differences in plasma protein binding.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7357814     DOI: 10.1038/clpt.1980.78

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN: 0009-9236            Impact factor:   6.875


  12 in total

Review 1.  The pharmacokinetic behaviour of opioids administered during cardiac surgery.

Authors:  R Hall
Journal:  Can J Anaesth       Date:  1991-09       Impact factor: 5.063

2.  A novel protocol for antibiotic prophylaxis based on preoperative kidney function in patients undergoing open heart surgery under cardiopulmonary bypass.

Authors:  Mizuho Odaka; Kenji Minakata; Hideaki Toyokuni; Kazuhiro Yamazaki; Atsushi Yonezawa; Ryuzo Sakata; Kazuo Matsubara
Journal:  Gen Thorac Cardiovasc Surg       Date:  2015-04-30

3.  Prospective, open-label investigation of the pharmacokinetics of daptomycin during cardiopulmonary bypass surgery.

Authors:  Megan H Nguyen; Samantha J Eells; Jennifer Tan; Corinne T Sheth; Bassam Omari; Margarita Flores; Jeffrey Wang; Loren G Miller
Journal:  Antimicrob Agents Chemother       Date:  2011-03-28       Impact factor: 5.191

Review 4.  Effect of cardiopulmonary bypass on the pharmacokinetics of drugs.

Authors:  F O Holley; K V Ponganis; D R Stanski
Journal:  Clin Pharmacokinet       Date:  1982 May-Jun       Impact factor: 6.447

Review 5.  Ceforanide. A review of its antibacterial activity, pharmacokinetic properties and clinical efficacy.

Authors:  D M Campoli-Richards; T E Lackner; J P Monk
Journal:  Drugs       Date:  1987-10       Impact factor: 9.546

6.  Single-dose antimicrobial prophylaxis in open heart surgery.

Authors:  T Beam; T Raab; J Spooner; S Balderman; J Aldridge; J Bhayana
Journal:  Eur J Clin Microbiol       Date:  1984-12       Impact factor: 3.267

7.  Alcuronium kinetics in patients undergoing cardiopulmonary bypass surgery.

Authors:  J S Walker; K F Brown; C A Shanks
Journal:  Br J Clin Pharmacol       Date:  1983-02       Impact factor: 4.335

8.  Penetration of ceforanide and cefamandole into the right atrial appendage, pericardial fluid, sternum, and intercostal muscle of patients undergoing open heart surgery.

Authors:  L D Mullany; M A French; C H Nightingale; H B Low; L H Ellison; R Quintiliani
Journal:  Antimicrob Agents Chemother       Date:  1982-03       Impact factor: 5.191

9.  The effect of cardiopulmonary bypass on plasma protein binding of alfentanil.

Authors:  K Kumar; D P Crankshaw; D J Morgan; G H Beemer
Journal:  Eur J Clin Pharmacol       Date:  1988       Impact factor: 2.953

10.  Ceftriaxone disposition in open-heart surgery patients.

Authors:  G L Jungbluth; M T Pasko; T R Beam; W J Jusko
Journal:  Antimicrob Agents Chemother       Date:  1989-06       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.